Acetylcholinesterase activity and biogenic amines in phenylketonuria

Clinical Chemistry

Volumn 48, Issue 10, 2002, Pages 1794-1796

  Schulpis, Kleopatra H ^a   Karikas, George A ^a   Tjamouranis, Joanna ^a   Michelakakis, Helen ^a   Tsakiris, Stylianos ^a  

^a AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; ADRENALIN; BIOGENIC AMINE; DOPAMINE; NORADRENALIN; PHENYLALANINE; SEROTONIN; TRYPTOPHAN; TYROSINE;

ARTICLE; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ERYTHROCYTE MEMBRANE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INBORN ERROR OF METABOLISM; METABOLIC DISORDER; PHENYLKETONURIA; QUANTITATIVE ANALYSIS;

EID: 0036791410     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/48.10.1794     Document Type: Article

References (25)

1. Scriver C, Kaufman S, Eisensmith R, Woo S. The hyperphenylalaninemias. In: Scriver C, Beaudet A, Sly W, Valle D, eds. The metabolic and molecular bases of inherited disease, 8th ed. New York: McGraw-Hill, 2000:1775-875.
2. Missiou-Tsagaraki S, Soulpi K, Loumakou M. Phenylketonuria in Greece: 12 years experience. J Ment Defic Res 1988:32:271-87.
3. Curtius H, Wiederwieser C, Viscontini G, Leimbacher M, Wegman H, Schmidt H. Serotonin and dopamine synthesis in phenylketonuria. Adv Exp Med Biol 1981;133:277-91.
4. Krause W, Halminski M, McDonald L. Biochemical and neuropsychological effects of elevated plasma phenylalanine in patients with treated phenylketonuria. J Clin Invest 1985;75:40-8.
5. Blau K. Phenylalanine hydroxylase deficiency: biochemical, psychological and clinical aspects of phenylketonuria and related hyperphenylalaninemias, In: Youdim MBH, ed. Aromatic amino acids, hydroxylases, and mental diseases. New York: Wiley, 1979;77-139.
6. Aragon MC, Gimenez G, Valdinieso F. Inhibition by phenylalanine of tyrosine transport by synaptosomal plasma membrane vesicles: implication in the pathogenesis of phenylketonuria. J Neurochem 1982;39:1185-7.
7. Herrero E, Aragon MC, Gimenez C, Valdivieso F, Inhibition by L-phenylalanine of tryptophan transport by synaptosomal plasma membrane vesicles: implication in the pathogenesis of phenylketonuria. J Inherit Metab Dis 1983;6:32-5.
8. Lotti M. Cholinesterase inhibition: complexities in interpretation. Clin Chem 1995;41:1814-8.
9. Sussman JL, Harrel M, Frolow F, Goldman A. Atomic structure of acetylcholinesterase from Torpedo california: a prototypic acetylcholine binding protein. Science 1991;253:872-80.
10. Deliconstantinos G, Tsakiris S. Differential effect of anionic and cationic drugs on the synaptosome associated acetylcholinesterase activity of dog brain. Biochem J 1985;229:81-9.
11. Egashira T, Goto H, Takda H, Takada K, Matsumiya T. Alterations in neurotransmitter, amino acid and free radical related substances in cerebrospinal fluid in patients with cerebrovascular diseases. Nippon Ronen Igakkai Asshi 1999;36:256-61.
12. Schulpis KH, Karikas GA, Tjamouranis J. In vitro influence of phenylalanine on acetylcholinesterase activity and DNA. Z Naturforsch 1998;53c:291-3.
13. +-ATPase. Z Naturforsch 1998;53c:1055-60.
14. +-ATPase. Z Naturforsch 1998;58c:163-8.
15. Galbraith DA, Watts DC. Human erythrocyte acetylcholinesterase in relation to cell age. Biochem J 1981;195:221-8.
16. Kamber E, Poyigi A, Deliconstantinos G. Modifications in the activities of membrane-bound enzymes during in vivo ageing of human and rabbit erythrocytes. Comp Biochem Physiol 1984;77B:95-9.
17. Lowry OH, Rosebrough NJ, Farr AL, Randal RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-75.
18. Ellman GL, Gourtney D, Andres V, Featherstone RM. A new rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961;7:88-95.
19. +ATPase activities in adult and aged rat brain. Mech Ageing Dev 2001;122:491-501.
20. Faggiano A, Pivonello R, Melis D, Alfiori R, Filippela M, Spagnuolo G, et al. Evaluation of circulating levels and renal clearance of natural amino acids in patients with Cushing disease. J Endocrinol Invest 2002;25:142-151.
21. Candito M, Albertini M, Politanos S, Deville A, Mariani S. Plasma catecholamine levels in children. J Chromatogr 1993;617:304-7.
22. Kema J, Meijer WG, Meiborg G, Ooms B, Willense PA, De Vries E. Profiling of tryptophan-related plasma indoles in patients with carcinoid tumors by automated on line solid extraction and HPLC with fluorescence detection. Clin Chem 2001;47:1811-20.
23. Schulpis KH, Papakonstantinou E, Michelakakis H, Theodoridis T, Papadreou U, Constantopoulos A. Elevated serum prolactin concentrations in phenylketonuric patients on a "loose diet". Clin Endocrinol 1998;48:99-101.
24. Shafferman A, Ordentlich A, Barak D. Stein D, Ariel N, Velan B. Aging of phosphorylated human acetylcholinesterase: catalytic processes mediated by aromatic and polar residues of the active centre. Biochem J 1998;318:833-40.
25. Ohue T, Koshimura K, Lee K, Watanabe Y, Miwa S. A novel action of 6R-L-erythro·5,6,7,8-tetrahydrobiopterin, a cofactor of hydroxylases of phenylalanine, tyrosine and tryptophan: enhancement of acetylcholine release in vivo in the rat hippocampus, Neurosci Lett 1991;128:93-6.